Apex Critical Metals Braces for Dual Catalysts at Nebraska Rare Earths: Assay Results, Metallurgical Studies in Focus

Apex Critical Metals shares rebound 8% but remain 68% below high. With 12 drill assays pending, metallurgical testing underway, and U.S. DoD consortium entry, the stock’s next move depends on hard data.

Investors in Apex Critical Metals are caught between a near-term bottleneck and a long-term promise. The explorer’s Frankfurt-listed shares jumped more than 8% on Friday to €0.97, but the rebound did little to mask a brutal 27% monthly decline. The stock now trades nearly 68% below its 52-week high of €3.00, reflecting the market’s impatience for hard geological data.

That data is finally moving through the pipeline. Apex has completed 18 drill holes totalling 12,000 metres at its “Rift” rare earths project in Nebraska, but assay results for 12 of those holes are still pending. While the wait grinds on, the company has quietly pivoted to the next phase: metallurgical testing. Actlabs and SGS Lakefield are now analysing selected rock samples to determine the exact mineralogical composition of the rare earths, laying the groundwork for eventual extraction methods. A formal contract with SGS for a full metallurgical test program is expected within weeks.

The preliminary findings from the six completed assays have already outlined two distinct mineralised zones, and the early data is turning heads. The shallower “Trinity” zone carries high concentrations of rare earth oxides, while the deeper “Neo” zone boasts a neodymium-praseodymium (NdPr) ratio exceeding 30% — well above the global average of 14% to 20% for similar deposits. NdPr is the critical ingredient for the high-strength permanent magnets used in electric motors, making it the most valuable component of the project.

Apex is accelerating its exploration program in parallel with the lab work. Originally budgeted at 8,000 metres, the drill campaign has been upsized to up to 25,000 metres, with a target completion date by September 2026. The expanded dataset will feed directly into the company’s first official resource estimate, slated for the first quarter of 2027. That milestone is the linchpin for the investment case.

Backing the geological push is a strategic endorsement from the U.S. Department of Defense, which has admitted Apex into its Defense Industrial Base Consortium (DIBC). The initiative is designed to secure domestic supply chains for critical minerals essential to national security, including rare earths used in advanced weapons systems and aerospace. The move sets Apex apart from the pack of junior explorers vying for government support.

For now, the stock’s trajectory hinges on the 12 pending assay results. On a 12-month view, the shares have still gained 93%, and the relative strength index sits at 40.5 — not yet oversold but showing room for a bounce. Once the lab data lands, the market will have a far clearer picture of whether Apex can turn its Nebraska prospect into a resource that matters.